Irreversible Pepsin Fraction (IPF)
IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
Immune Therapeutic Vaccine-1 (ITV-1)
Our flagship compound ITV-1 is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
Immune Therapeutic Vaccine (ITV) is a Fusion Inhibitor and Immunomodulator, which can be used for exploring this therapeutic avenue, and explains the promising results of extensive laboratory testing.